Cabozantinib has promise with bone mets: "Treatment of animals - TopicsExpress



          

Cabozantinib has promise with bone mets: "Treatment of animals with cabozantinib resulted in substantial inhibition of tumor growth, induction of tumor cell death, and blockade of cancer-induced bone remodeling as determined by bioluminescence imaging, MRI, micro-CT, and histological analyses. In addition, imaging studies showed that early reductions in the uptake of the bone scan tracer 99Tc-MDP were associated with the anti-tumor activity of cabozantinib in mice." - this is not ASPS - a different vascular solid CA businesswire/news/home/20130507007129/en/Exelixis-Announces-Quarter-2013-Financial-Results
Posted on: Thu, 06 Jun 2013 04:48:43 +0000

Trending Topics



Recently Viewed Topics




© 2015